HeartCore Reports Second Quarter 2026 Financial Results

HeartCore Enterprises, Inc. (HTCR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 HeartCore Reports Second Quarter 2026 Financial Results NEW YORK and TOKYO, August 13, 2026 (GLOBE NEWSWIRE) – HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”) , an IPO consulting services company based in Tokyo, reported financial results fo

Original reporting
Published Aug 13, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 12:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HTCR
Bearish
medium confidence
Mentioned
$HTCR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HTCRBearishMed
01

Why it matters

Traders can reassess near-term risk around profitability trajectory and liquidity, while also weighing the strategic focus shift toward Go IPO consulting and planned financial services.

02

Market read

Revenue growth and Nasdaq compliance are positives, but widening losses and low cash increase downside risk and may drive volatility around the next earnings cycle.

03

What to watch

Cash and cash equivalents are very low ($587k), so any follow-on financing risk could dominate valuation even if revenue growth continues.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (Aug 13, 2026) with Q2 and six-month financials

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting HeartCore’s Q2 2026 financial results and operational updates, including divestitures and Nasdaq compliance status.

Company-level read

Ticker impact

$HTCRBearishMedium confidence
Context

HeartCore reported Q2 2026 results, including 71.6% revenue growth to $321k and a net loss of $2.0m, plus portfolio divestitures.

Expected impact

Near-term downside bias is plausible if investors focus on losses and cash burn, partially offset by the Nasdaq compliance and divestiture narrative.

Evidence & confidence

Revenue rose sharply, but gross loss widened and Adjusted EBITDA loss deepened; cash was only $587k as of June 30, while the company also announced divestiture steps and regained $1.00 bid compliance.

Market effects

Limited read-through to the broader IPO consulting/software services space; this is primarily company-specific.

Mostly relevant to Japan-focused listing-advisory and cross-border capital markets services sentiment.

Low, as the disclosure is not a macro or industry-wide shock.

Counterpoint

Investors may treat the gross loss and deeper Adjusted EBITDA as transitional costs tied to improving the Go IPO customer experience and restructuring, with divestitures simplifying the model.

Key entities

  • HeartCore Enterprises, Inc.

    Nasdaq-listed IPO consulting and related advisory services firm reporting Q2 2026 results and portfolio optimization actions.

  • Luvina Software Joint Stock Company

    Agreed to divest HeartCore’s 51% equity interest in HeartCore Luvina Vietnam Company Limited.

  • Sigmaways, Inc.

    Strategic divestiture completed, concentrating HeartCore on Go IPO consulting and related services.

Related articles

$HTCRMed

HeartCore Enterprises, Inc. (HTCR): Completion of Acquisition or Disposition of Assets

HeartCore Enterprises, Inc. (HTCR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 STOCK AND DEBT PURCHASE AGREEMENT Date: June 22, 2026 THIS STOCK AND DEBT PURCHASE AGREEMENT (this “Agreement”) is entered into as of June 22, 2026, by and between (i) HeartCore Enterprises, Inc. (“HeartCore” or “Seller”) and (ii) Semapho

$NEONMed

Neonode Reports Quarter Ended September 30, 2026 Financial Results

Neonode Inc. (NEON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Press Release For Release, 9:10AM ET November 12, 2026 Neonode Reports Quarter Ended September 30, 2026 Financial Results STOCKHOLM, SWEDEN, November 12, 2026 — Neonode Inc. (NASDAQ: NEON) (“Neonode” or the “Company”) today reported financial results for the three an

$UGMed

United-Guardian 3Q 2026: Revenue $3.49M, EPS $0.2 — 10-Q Summary

United-Guardian reported 3Q 2026 revenue of $3.49M, up 54% YoY, with EPS of $0.2. Growth was driven by pharmaceuticals, cosmetic ingredients, and medical lubricants. Pharmaceutical sales rose 29% due to Renacidin formulary coverage, while cosmetic ingredient sales climbed 187% after ASI resumed purchases. Medical lubricant sales increased 20%, and cost of sales fell to 46% of revenue.

$CLBTHighAI 9/10

Why is Cellebrite stock surging today?

Cellebrite's stock rose 5.9% in pre-market trading after Q3 2026 results beat expectations, with non-GAAP EPS of $0.17 vs. $0.10 consensus. Annual recurring revenue grew 20% YoY to $528.5M. The company raised its 2026 adjusted EBITDA outlook to $163M-$166M. CEO Shiv Ramji cited strong international and U.S. Federal performance. Operating cash flow increased 70% to $56.58M.

$SSYSHigh

Why is Stratasys stock rallying today?

Stratasys (SSYS) stock rose 4.7% in pre-market trading after reporting Q3 2026 earnings that exceeded expectations, with adjusted EPS of $0.04 vs. $0.02 consensus. Revenue increased 4.1% YoY to $142.6M, and the company narrowed its GAAP net loss to $10.2M. The company has no debt and $210.7M in cash. Full-year revenue guidance was set at $556M–$561M, slightly below consensus. The rally occurred despite a weak broader market.